blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1202754

EP1202754 - USE OF FIBRINOGEN MULTIMERS IN FIBRIN SEALANTS [Right-click to bookmark this link]
StatusPatent revoked
Status updated on  14.11.2008
Database last updated on 19.10.2024
Most recent event   Tooltip14.11.2008Revocation of patentpublished on 17.12.2008  [2008/51]
Applicant(s)For all designated states
OMRIX BIOPHARMACEUTICALS S.A.
200 Chaussée de Waterloo
1640 Rhode-St-Genèse / BE
[2002/19]
Inventor(s)01 / BAR, Lily
Weitzmann Science Park P.O. Box 619
76106 Rehovot / IL
02 / NUR, Israel
Weitzmann Science Park P.O. Box 619
76106 Rehovot / IL
 [2002/19]
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2002/19]Schreiber, Christoph, Dr., et al
Patentanwälte von Kreisler Selting Werner, Postfach 10 22 41
50462 Köln / DE
Application number, filing date00958430.111.08.2000
[2002/19]
WO2000EP07843
Priority number, dateEP1999011595813.08.1999         Original published format: EP 99115958
EP2000010849919.04.2000         Original published format: EP 00108499
[2002/19]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0112244
Date:22.02.2001
Language:EN
[2001/08]
Type: A1 Application with search report 
No.:EP1202754
Date:08.05.2002
Language:EN
The application published by WIPO in one of the EPO official languages on 22.02.2001 takes the place of the publication of the European patent application.
[2002/19]
Type: B1 Patent specification 
No.:EP1202754
Date:29.10.2003
Language:EN
[2003/44]
Search report(s)International search report - published on:EP22.02.2001
ClassificationIPC:A61L24/10, A61P41/00
[2003/09]
CPC:
A61L24/106 (EP); A61P41/00 (EP)
Former IPC [2002/19]A61L24/10
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2002/19]
Extension statesALNot yet paid
LTNot yet paid
LVNot yet paid
MKNot yet paid
RONot yet paid
SINot yet paid
TitleGerman:VERWENDUNG VON FIBRINOGEN-MULTIMEREN IN FIBRINKLEBERN[2002/19]
English:USE OF FIBRINOGEN MULTIMERS IN FIBRIN SEALANTS[2002/19]
French:UTILISATION DE MULTIMERES DE FIBRINOGENE[2002/19]
Entry into regional phase22.01.2002National basic fee paid 
22.01.2002Designation fee(s) paid 
22.01.2002Examination fee paid 
Examination procedure28.02.2001Request for preliminary examination filed
International Preliminary Examining Authority: EP
22.01.2002Examination requested  [2002/19]
06.09.2002Despatch of a communication from the examining division (Time limit: M04)
04.10.2002Reply to a communication from the examining division
27.03.2003Communication of intention to grant the patent
26.06.2003Fee for grant paid
26.06.2003Fee for publishing/printing paid
Opposition(s)Opponent(s)01  28.07.2004  09.08.2004  ADMISSIBLE
CSL Behring GmbH
Emil-von-Behring-Strasse 76
35041 Marburg / DE
Opponent's representative
Pfeil, Hugo, et al, et al
CSL Behring GmbH Patents & Licences Postfach 1230
35002 Marburg / DE
 [2008/22]
Former [2004/39]
Opponent(s)01  28.07.2004   
ZLB Behring GmbH
Postfach 1230
35002 Marburg / DE
Opponent's representative
Pfeil, Hugo, Dr., et al, et al
ZLB Behring GmbH, Intellectual Property/Legal, Postfach 1230
35002 Marburg / DE
06.09.2004Invitation to proprietor to file observations on the notice of opposition
27.04.2005Reply of patent proprietor to notice(s) of opposition
03.05.2005Communication of observations of patent proprietor (Time limit: M04)
24.08.2005Reply of parties involved to observations of patent proprietor
19.06.2008Date of oral proceedings
19.06.2008Legal effect of revocation of patent [2008/51]
31.07.2008Despatch of minutes of oral proceedings
31.07.2008Despatch of communication that the patent will be revoked
Fees paidRenewal fee
16.10.2002Renewal fee patent year 03
28.08.2003Renewal fee patent year 04
Penalty fee
Additional fee for renewal fee
31.08.200203   M06   Fee paid on   16.10.2002
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY29.10.2003
FI29.10.2003
GR29.01.2004
LU11.08.2004
MC31.08.2004
[2007/08]
Former [2005/23]FI29.10.2003
GR29.01.2004
MC31.08.2004
Former [2004/33]FI29.10.2003
GR29.01.2004
Former [2004/26]FI29.10.2003
Cited inInternational search[A]US4362567  (SCHWARZ OTTO, et al) [A] 1-8* the whole document *;
 [A]US4650678  (FUHGE PETER [DE], et al) [A] 1-8 * the whole document *;
 [X]US4960757  (KUMPE GERHARDT [DE], et al) [X] 1-8 * the whole document *;
 [A]EP0856317  (OMRIX BIOPHARM SA [BE]) [A] 5-8 * page 2, line 22 - line 40 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.